
    
      At present study, the investigators will use endothelin receptor antagonist, Tracleer
      (Bosentan), to investigate the effect of Tracleer on tourniquet-associated hypertension
      during unilateral total knee arthroplasty, and evaluate its safety and effectivity. The
      purpose of this study is to find a new therapy to prevent and treat tourniquet-associated
      hypertension.
    
  